Celyad SA ADR Stock
Your prediction
Celyad SA ADR Stock
Our community identified positive and negative aspects for Celyad SA ADR stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Celyad SA ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Celyad SA ADR in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Celyad SA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Celyad SA ADR | - | - | - | - | - | - | - |
| Cardio3 Biosciences S.A. | -9.960% | -12.000% | -20.000% | -38.375% | 62.963% | -53.291% | -95.524% |
| Intellia Therapeutics Inc | 4.170% | -6.050% | -11.706% | 42.510% | 35.281% | -73.770% | -84.548% |
| Chromadex Corp | -0.670% | 2.740% | -14.773% | -74.138% | -45.455% | 102.703% | -63.636% |